Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Shu-Fen Sun, MD
Woman and Man Max 99 years
Shu-Fen Sun, MD
Update Il y a 4 ans
Efficacy of Three Weekly Injections of a Bacterial-- Sourced Hyaluronate on Pain and Function in Patients With Knee Osteoarthritis (OA)
Three weekly injections of hyaluronate (Hya-Joint) are safe and well tolerated, provide rapid pain relief as early as 1 and 2 weeks after the first injection, and improve function in patie...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shu-Fen Sun, MD
Update Il y a 4 ans
Efficacy of 3 Weekly Injections of Hyaluronate in Patients With Ankle Osteoarthritis
The aim of this study was to investigate the efficacy and safety of three weekly intraarticular injections of Hyaluronate (HA) in patients with unilateral ankle Osteoarthritis (OA).
Country
Taiwan, Province of China
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shu-Fen Sun, MD
Update Il y a 4 ans
Combined NMES,FEES and Traditional Swallowing Rehabilitation in the Treatment of Stroke-related Dysphagia
The investigators aimed to evaluate effects of combined NMES, FEES and traditional swallowing rehabilitation in stroke patients with moderate-to-severe dysphagia.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shu-Fen Sun, MD
Update Il y a 4 ans
Effects of Intraarticular Botulinum Toxin A in Ankle Osteoarthritis
The purpose of this study is to compare the effects of intraarticular Botulinum Toxin A versus intraarticular hyaluronate plus rehabilitation exercise in patients with ankle osteoarthritis...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Shu-Fen Sun, MD
Update Il y a 4 ans
Botulinum Toxin Type A and Modified Constraint-Induced Movement Therapy for Poststroke Upper Extremity Spasticity
Botulinum toxin type A (BtxA) injection and modified constraint-induced movement therapy (mCIMT) are both promising approaches to enhance recovery after stroke. However, the combined appli...
Country
None
organs
None
Specialty
None
Closed trial
More information